| Optimistic bias and preventive behavioral engagement in the context of COVID-19 T Park, I Ju, JE Ohs, A Hinsley Research in Social and Administrative Pharmacy 17 (1), 1859-1866, 2021 | 182 | 2021 |
| Direct-to-consumer antidepressant advertising and consumers’ optimistic bias about the future risk of depression: the moderating role of advertising skepticism JS Park, I Ju, KE Kim Health communication 29 (6), 586-597, 2014 | 35 | 2014 |
| Prescription drug advertising, disease knowledge, and older adults’ optimistic bias about the future risk of Alzheimer’s disease JS Park, I Ju Health Communication 31 (3), 346-354, 2016 | 29 | 2016 |
| Communication strategies in direct-to-consumer prescription drug advertising (DTCA): Application of the six segment message strategy wheel I Ju, JS Park Journal of health communication 20 (5), 546-554, 2015 | 24 | 2015 |
| Interpersonal communication influence on health-protective behaviors amid the COVID-19 crisis I Ju, J Ohs, T Park, A Hinsley Health Communication 38 (3), 468-479, 2023 | 23 | 2023 |
| The effects of advertising skepticism in consumer prescription drug advertising: The moderating role of risk disclosure location I Ju International Journal of Pharmaceutical and Healthcare Marketing 11 (4), 395-411, 2017 | 14 | 2017 |
| When numbers count: Framing, subjective numeracy, and the effects of message quantification in direct-to-consumer prescription drug advertisements I Ju, JS Park Journal of Promotion Management 19 (4), 488-506, 2013 | 13 | 2013 |
| Information seeking during the COVID-19 pandemic: Application of the risk information seeking and processing model T Park, I Ju, JE Ohs, A Hinsley, J Muzumdar Research in Social and Administrative Pharmacy 19 (6), 956-964, 2023 | 10 | 2023 |
| Consumer’s regulatory knowledge of prescription drug advertising and health risk awareness: the moderating role of risk information prominence I Ju, JE Ohs, JS Park Health Communication, 2019 | 10 | 2019 |
| Consumer responses to covert marketing communications: A case of native advertising disclosure in news contexts I Ju, H Lee, B Sherrick Journal of Promotion Management 28 (7), 1107-1128, 2022 | 9 | 2022 |
| Marketing communication I Ju The international encyclopedia of strategic communication, 1-14, 2018 | 6 | 2018 |
| Dynamics of consumer decision making of over-the-counter drugs: evaluating product comparison claims and moderating role of price consciousness I Ju, H Lee Journal of Communication in Healthcare 10 (2), 88-99, 2017 | 6 | 2017 |
| Examining the theory of motivated information management (TMIM) in the COVID-19 pandemic I Ju, J Ohs, T Park, A Hinsley Journal of Health Communication 27 (5), 326-342, 2022 | 4 | 2022 |
| Consumer engagement with prescription medicine decisions: Influences of health beliefs and health communication sources I Ju, T Park, JE Ohs Health Communication, 2018 | 4 | 2018 |
| Effects of risk disclosure prominence in direct-to-consumer advertising (DTCA) of prescription drugs: An integrative cognitive process model I Ju, JS Park Health Marketing Quarterly 35 (1), 32-46, 2018 | 4 | 2018 |
| Thinking about fair balance: how prescription drug advertising disclosure prominence works? I Ju International Journal of Pharmaceutical and Healthcare Marketing 11 (1), 2-15, 2017 | 3 | 2017 |
| How do consumers cope with prescription drug advertising messages? risk disclosure presentation order, advertising skepticism, and perceived risk disclosure voluntariness I Ju, E Haley American Academy of Advertising. Conference. Proceedings (Online), 153, 2014 | 3 | 2014 |
| Harnessing an Integrated Health Communication (IHC) framework for campaigns: A case of prescription drug decision making I Ju, J Ohs, T Park, A Hinsley Health Communication 38 (5), 981-992, 2023 | 2 | 2023 |
| Optimistic Bias and Consumer Prescription Drug Decisions: Influences of Direct to Consumer Advertising and Perceived Susceptibility I Ju, T Park, J Ohs Health Communication 37 (13), 1694-1703, 2022 | 1 | 2022 |
| The Effects of Risk Disclosure in Direct-to-Consumer Prescription Drug Advertising (DTCA): Prominence, DTCA Regulatory Knowledge, and Perceived Attention I Ju | 1 | 2014 |
